Filgotinib maleate is the maleate salt form of filgotinib, a selective Janus kinase 1 (JAK1) inhibitor. As an active pharmaceutical ingredient, it is used in the manufacturing of oral formulations intended for research in inflammatory and autoimmune diseases.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1802998-75-9
Filgotinib
pharmaceutical raw material
Clazosentan
pharmaceutical raw material
(1S,3S)-Solifenacin Hydrochloride
pharmaceutical raw material
CT7001 hydrochloride
pharmaceutical raw material
Ethyl 3,4-difluoro-2-methoxyphenylacetate
pharmaceutical raw material
(Z)-but-2-enedioic acid;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
BFENHEAPFWQJFL-BTJKTKAUSA-N
C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5.C(=C\C(=O)O)\C(=O)O